COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?
COVID-19: What do we need to know about ICU delirium during the SARS-CoV-2 pandemic?
复制标题
DOI:
10.5114/ait.2020.95164
复制
发表时间:
2020
影响因子:
1.7
通讯作者:
Dabrowski W
中科院分区:
文献类型:
--
作者:
Kotfis K;Williams Roberson S;Wilson J;Pun B;Ely EW;Jeżowska I;Jezierska M;Dabrowski W
In March 2020, the World Health Organisation announced the COVID-19 pandemic caused by the SARS-CoV-2 virus. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement, including delirium occurring in critically ill patients (ICU delirium). Due attention must be paid to this subject in the face of the COVID-19 pandemic. Delirium, the detection of which takes less than two minutes, is frequently underestimated during daily routine ICU care, but it may be a prodromal symptom of infection or hypoxia associated with severe respiratory failure. During the COVID-19 pandemic, systematic delirium monitoring using validated tests (CAM-ICU or ICDSC) may be sacrificed. This is likely to be due to the fact that the main emphasis is placed on organisational issues, i.e. the lack of ventilators, setting priorities for limited mechanical ventilation options, and a shortage of personal protective equipment. Early identification of patients with delirium is critical in patients with COVID-19 because the occurrence of delirium may be an early symptom of worsening respiratory failure or of infectious spread to the CNS mediated by potential neuroinvasive mechanisms of the coronavirus. The purpose of this review is to identify problems related to the development of delirium during the COVID-19 epidemic, which are presented in three areas: i) factors contributing to delirium in COVID-19, ii) potential pathophysiological factors of delirium in COVID-19, and iii) long-term consequences of delirium in COVID-19. This article discusses how healthcare workers can reduce the burden of delirium by identifying potential risk factors and difficulties during challenges associated with SARS-CoV-2 infection.
登录
查看更多内容
影响因子:
8.8
作者:
Girard TD;Jackson JC;Pandharipande PP;Pun BT;Thompson JL;Shintani AK;Gordon SM;Canonico AE;Dittus RS;Bernard GR;Ely EW
通讯作者:
Ely EW
DOI:
10.1016/j.jhin.2010.04.027
发表时间:
2010-10
期刊:
The Journal of hospital infection
影响因子:
--
作者:
Abad C;Fearday A;Safdar N
通讯作者:
Safdar N
DOI:
10.1016/j.clim.2016.05.009
发表时间:
2018-04
期刊:
Clinical immunology (Orlando, Fla.)
影响因子:
--
作者:
Grist JJ;Marro B;Lane TE
通讯作者:
Lane TE
影响因子:
8.8
作者:
Ely, EW;Margolin, R;Inouye, SK
通讯作者:
Inouye, SK
影响因子:
--
作者:
Han, L;McCusker, J;Élie, M
通讯作者:
Élie, M